MedPath

Effect of Hyaluronic Acid with PRF and PRF alone in the management of intrabony defects with the help of cone beam computed tomography

Phase 3
Not yet recruiting
Conditions
chronic periodontitis
Chronic periodontitis,
Registration Number
CTRI/2023/06/053875
Lead Sponsor
Swargiya Dadasaheb Kalmegh Smruti Dental College and hospital
Brief Summary

Periodontitis is an infectious disease that causes destruction of the toothattachment apparatus. If periodontitis is left untreated it may result in progressive attachment loss that may eventually lead to early tooth loss.1The soft and hard tissue loss occurred as a result of periodontitis, cannot be managed successfully by nonsurgical therapy alone and requires modalities for the regeneration of lost tissues.In halting the progression of periodontitis and maintaining disease related defects conventional periodontal treatments such as scaling, root planning and open flap debridement are highly effective.2For osseous, furcation and recession defects periodontal regenerative procedures are included such as soft tissue grafts, bone replacement grafts, root biomodifications, guided tissue regeneration, and combinations thereof.3Advances in understanding the inflammatory mechanisms and wound healing processes associated with periodontal diseases have led researchers to study the potential of numerous extracellular matrix components as promoters of periodontal healing and regeneration.4Hyaluronic Acid (HA) is one such natural extracellular matrix component, which plays a vital role in the functioning of extracellular matrices, including those of the periodontium. HA significantly increases the tensile strength of granulation tissue, initiates angiogenesis, stimulates clot formation, and augments bone formation.4Through increased mesenchymal cell differentiation and migrationHyaluronic Acid augments osteoblastic bone formation. In the morphologically healing of bone wounds HA provides the potential means for accelerating new bone formation.5There are several growth factors that are used in order for bone healing and bone regeneration. PRF(PLATELET RICH FIBRIN) is an autologous fibrin with abundance of platelets and leukocyte cytokines. PRF contains proportionately highlevels of growth factors, including the platelet-derived growth factor (PDGF), TGF, vascular endothelial growth factor, insulin-like growth factor (IGF), and epidermal growth factor (EGF).In bone grafting or bone defect healing, the growth factors play a centralrole in bone regeneration process and in hemostasis which makes PRFmore advantageous.6 Cone beam computed tomography (CBCT) provides a 3-dimensional (3D) view of the maxillofacial complex. Visualization of periodontal bone defects in 3 dimensions can be valuable because it has been shown that the healing of these defects is highly dependent on defect anatomy. . Therefore, the outcome of the treatment is predicted on an accurate examination of the defect’s anatomy.7To the best of our knowledge no studies have been carried out comparing the use of combination of Hyaluronic Acid + PRF and PRF alone in intrabony defects.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
24
Inclusion Criteria
  • Systemically healthy patients.
  • Patients with mild to moderate chronic periodontitis with 2 & 3 walled intrabony defects.
  • Full mouth plaque scores should be less than 15%.
Exclusion Criteria
  • Patients who underwent flap surgery within 1year.
  • Teeth indicated for extraction.
  • Patients having habit of consuming tobacco in any form.
  • Pregnant and lactating women.
  • Patients on any drug therapy which may affect the outcome of present study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation of efficacy of Hyaluronic Acid in combination with PRF in intrabony defects clinically by measuring probing depth, relative attachment loss, plaque index and gingival index.baseline and 6 months
2)To evaluate the radiographic defect fill with the use of Hyaluronic Acidbaseline and 6 months
in combination with PRF and PRF alone in intrabony defectsbaseline and 6 months
by measuring defect depth, mesio-lingual defect width and bucco-lingual defect width.baseline and 6 months
Secondary Outcome Measures
NameTimeMethod
Evaluating the efficacy of Hyaluronic Acid in combination with PRF and PRF alone in intrabony defects, clinically by measuring clinical attachment loss, relative attachment loss, plaque index and gingival index and radiographically by measuring defect depth, mesio-lingual defect depth and bucco-lingual defect depthbaseline and 6 months

Trial Locations

Locations (1)

Swargiya Dadasaheb Kalmegh Smruti Dental College and hospital

🇮🇳

Nagpur, MAHARASHTRA, India

Swargiya Dadasaheb Kalmegh Smruti Dental College and hospital
🇮🇳Nagpur, MAHARASHTRA, India
dr saeeka deshmukh
Principal investigator
9307694719
skdeshmukh0@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.